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Although autologous tissue transplantation represents a valid approach for bone repair, it 
has encountered crucial barriers in therapeutic translation, not least the invasive process 
necessary for stem cell isolation. In recent years, the scientific community has made 
significant strides for identifying new treatment options, and great emphasis has been 
placed on the tight interaction between skeletal and immune system in modulating the 
outcome of bone repair. Within the context of specific injury environmental cues, the 
cross talk among inflammatory cells and tissue resident and/or circulating progenitor 
cells is crucial to finely coordinate repair and remodeling processes. The appropriate 
modulation of the inflammatory response can now be considered a new trend in the field 
of regenerative medicine, as it raises the attracting possibility to enhance endogenous 
progenitor cell functions, finally leading to tissue repair. Therefore, new treatment options 
have been developed considering the wide spectrum of bone–inflammation interplay, 
considering in particular the cell intrinsic cues responsible for the modulation of the 
injured environment. In this review, we will provide a panoramic overview focusing on 
novel findings developed to uphold endogenous bone repair.
Keywords: inflammation, injury microenvironment, bone repair, endogenous progenitor cells, circulating 
progenitor cells, skeletal progenitor cells, regenerative medicine
inTRODUCTiOn
Bone regeneration represents a series of biological events orchestrated by a large number of media-
tors and cellular elements leading to cell recruitment, proliferation, and differentiation (Einhorn and 
Gerstenfeld, 2014). Most skeletal fractures heal in the first 8 weeks without major clinical concerns 
(Marsell and Einhorn, 2011). However, in the case of impaired bone healing, fractures can be associ-
ated with a range of complications (Kostenuik and Mirza, 2017). Conventionally, if no healing is 
detectable after 4 months, the fracture can be considered a delayed union. If the failure of the fracture 
to consolidate persists for more than 6 months, it can be considered a non-union (Marsh, 1998). The 
dynamic process underlying bone healing involves the interactions of cells, cytokines and matrix 
and requires concerted events, consisting of early inflammatory response, hard callus formation, 
and bone union followed by remodeling (Giannoudis et  al., 2007; Gómez-Barrena et  al., 2015). 
Bone autograft is the harmless and most efficient grafting procedure. However, due to limitations 
related to quantity and harvesting, “it represents an additional surgical intervention, with frequent 
consequences of pain and complications” (Roberts and Rosenbaum, 2012; Gómez-Barrena et al., 
2015). Having said that, the scientific community moved on to allograft, primarily hailing from 
tissue banks. Nevertheless, also this strategy could be impaired by virus-inactivation treatments and 
freezing procedures (Gómez-Barrena et al., 2015). Thus, it has been long searched for biocompatible 
materials, in combination or not with osteogenic factors, resembling the properties of the autografts 
(Giannoudis et  al., 2005), but none of them has reached the same osteogenic potential. In view 
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of these limitations, cell therapy can be considered an effective 
alternative to bone grafting (Rosset et  al., 2014). Until now, 
different osteoprogenitors have been used in combination with 
suitable scaffolds. However, the application of these approaches 
led to a limited clinical success due to several reasons, such as 
the high commercialization costs, the regulatory issues, as well as 
the hitches of clinical translation (Bruder and Fox, 1999; Amini 
et al., 2012).
Among the most important biological interactions involved 
in the bone healing process, the cross talk between skeletal and 
immune system has received great attention, enough to establish 
an interdisciplinary field named osteoimmunology (Greenblatt 
and Shim, 2013). The appropriate modulation of the inflamma-
tory response that occurs following tissue injury can be consid-
ered an important regulator of the bone repair cascade, leading 
to activation, mobilization, and recruitment of osteoprogenitors 
to the injured sites (Mountziaris and Mikos, 2008). In light of 
such considerations, the search is now on identifying the finest 
strategies to enhance and potentiate endogenous regenerative 
events for future therapy.
In this review, we will discuss the latest and most relevant 
findings on multiple features that impact fracture healing, with 
particular emphasis on the role of inflammation and progenitor 
cell recruitment.
inFLAMMATORY ReSPOnSeS inDUCeD 
BY FRACTURe HeALinG
Platelet activation and concurrent inflammatory reaction are the 
first tissue responses to damage. The sum of biological effects 
generated during these early phases will direct the entire healing 
process (Tasso et al., 2013). It is known that “a brief and highly 
regulated secretion of pro-inflammatory cytokines at the time of 
the acute injury is crucial for the healing process” (Marsell and 
Einhorn, 2011). Bone fracture leads to blood vessel disruption 
not only inside bone, but also in the adjacent soft tissues, and to 
a generalized damage of cells and tissues that, as a whole, induce 
a strong inflammatory reaction (Claes et al., 2012). The acutely 
inflamed surrounding tissues are characterized by vasodilatation 
and fast arrival of innate immune cells. Within the fracture gap, 
fibrinogen is converted in fibrin and the hematoma takes shape 
(Claes et al., 2012). The resulting environment is highly hypoxic 
and marked by low pH and strong infiltration of inflammatory 
cells and cytokines (Einhorn and Gerstenfeld, 2014). In this con-
text, literature data indicate that interleukin-6 (IL-6) and tumor 
necrosis factor-alpha (TNF-α) play key roles in the regulation of 
osteoclast activity by stimulating hematopoietic progenitor cells 
to differentiate along an osteoclastic lineage or enhancing the 
resorptive capacity of existing osteoclasts (Sarahrudi et al., 2009; 
Yokota et al., 2014). The idea that a certain degree of inflamma-
tion is required is reinforced by literature data indicating that 
treatment with anti-inflammatory drugs such as cyclooxygenase 
2 (COX-2) inhibitors impairs the fracture healing process (Claes 
et al., 2012). Indeed, COX-2 promotes both angiogenesis and dif-
ferentiation of mesenchymal stem cells (MSCs) into osteoblasts 
during fracture healing (Boursinos et al., 2017). To back this up, 
in 2011 Liu and colleagues have demonstrated that the in  situ 
administration of the non-steroidal anti-inflammatory drug aspi-
rin significantly promoted MSC-mediated bone repair in a mouse 
model of calvarial defect (Liu et al., 2011b). Moreover, the inhibi-
tion of NF-kB, a transcription factor involved in inflammation, 
or pathways leading to its activation improved “MSC-mediated 
craniofacial bone regeneration and repair in  vivo” contrasting 
β-catenin degradation (Chang et al., 2013). The involvement of 
the β-catenin pathway in bone repair was further demonstrated 
in a recent paper indicating that signaling associated with the 
danger molecule interleukin-1 receptor, type 1 (IL-1R1) impaired 
MSC activation and differentiation by inhibiting β-catenin path-
way (Martino et al., 2016).
The reason why the initial cell interactions are essential to 
obtain a correct repair is that innate immune cells guide revascu-
larization and reparative events at injury sites, promoting progeni-
tor cell migration (Figure 1). In 2012, a study was conducted to 
evaluate how biomaterials designed to incorporate inflammatory 
signals affected the behavior of natural killer (NK) cells, one of 
the first population arriving at the injury site, and the NK/MSC 
interactions. “It was found that NK cells are capable of stimulating 
a three-fold increase in human bone marrow MSC invasion, sug-
gesting the importance of designing novel biomaterials leading to 
rational modulation of the inflammatory response as an alterna-
tive to current bone regeneration strategies” (Almeida et al., 2012).
During the early inflammatory phase, polymorphonu-
clear leukocytes followed by blood monocytes/macrophages 
entrapped in the fibrin cloth release molecules that favor the 
chemoattraction of different cell types. Due to their plasticity, 
macrophages represent one of the most studied innate immune 
cell populations (Mantovani et  al., 2013). Classically activated, 
or M1, macrophages, whose prototypical activating stimulus is 
interferon-gamma (IFN-γ) and TNF-α (Varga et al., 2016) exhibit 
potent antimicrobial properties, high capacity to present antigen, 
and high interleukin-12 (IL-12) and IL-23 production (Verreck 
et al., 2004). In response to IL-4 and IL-13 signaling pathways, 
macrophages undergo an alternative activation, or M2, program 
that takes part in polarized Th2 responses, dampening of inflam-
mation, promotion of tissue remodeling (Wynn, 2004), and 
angiogenesis (Chambers et al., 2013). Recently, it has been sug-
gested a more appropriate nomenclature for macrophages based 
on “a set of standards encompassing three principles—the source 
of macrophages, definition of the activators, and a consensus col-
lection of markers to describe macrophage activation—with the 
goal of unifying experimental standards for diverse experimental 
scenarios” (Murray et al., 2014). Different studies indicate that the 
interaction with bona fide stem/progenitor cells is an important 
task of macrophages, and this is particularly true when these cells 
are in a M2 activation state (Lolmede et  al., 2009; Tasso et  al., 
2013). It has been reported that “depletion of macrophages led to 
early skeletal growth retardation and progressive osteoporosis” 
(Vi et al., 2015). Resident- and circulating macrophages recruited 
to the injury site exert pivotal functions for intramembranous and 
endochondral ossification, respectively (Claes et al., 2012). In vivo 
depletion of resident macrophages, named osteomacs, indicated 
that these cells were required for deposition of matrix expressing 
type I collagen and bone mineralization (Alexander et al., 2011). 
Conversely, when the fracture healing process was examined in 
FiGURe 1 | Schematic depicting endogenous regenerative responses underpinning bone tissue repair. The injury-generated environment is enriched of growth 
factors, chemokines, pro- and anti-inflammatory cytokines as well as hypoxic stimuli that evoke feedbacks to the niches, deploying programs for endogenous 
progenitor activation, mobilization, and recruitment to the healing site. The healing process involves either circulating progenitor cells or tissue-specific progenitors.
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CCR2−/− mice that underwent a non-stabilized tibial fracture 
that heals through robust endochondral ossification, an impaired 
vascularization and decreased callus formation associated with a 
lower number of circulating macrophages were observed (Xing 
et  al., 2010). The functional effect of macrophages on fracture 
healing has been recently confirmed using a preclinical model 
of osteotomy induced in rats subjected to splenectomy (Xiao 
et al., 2017). Moreover, studies conducted with human fracture 
tissues indicate that the presence of macrophages persists in the 
injured sites in association with areas of bone formation, even 
if their numbers are higher in early fracture samples (Andrew 
et al., 1994; Alexander et al., 2017). Overall, these data suggest 
that macrophage contribution to bone repair goes far beyond the 
early inflammatory events. Noteworthy, some recently published 
papers stressed the closed relationship between the adaptive 
immune system and the healing outcome. Mice totally lacking 
the adaptive immune system, as well as mice depleted of CD8+ 
T  lymphocytes are characterized by an enhanced endogenous 
fracture regeneration (Toben et al., 2011; Reinke et al., 2013).
The milieu induced by the initial inflammatory response 
together with the angiogenic factors released as an effect of the 
hypoxic condition generated within the fracture gap (Mirhadi 
et al., 2013), guide revascularization of the injured site, a central 
event not only for the re-establishment of a normoxic environ-
ment, but also because the newly formed blood vessels allow the 
direct interaction with host cells and provide the access to host 
osteoprogenitor cells, enhancing matrix deposition.
enDOGenOUS PROGeniTOR CeLLS  
in BOne RePAiR: LOCALLY ReSiDenT 
veRSUS CiRCULATinG PROGeniTORS
It has been described that signals associated with the environment 
generated by an injured bone stimulate the mobilization and pro-
liferation of both resident and circulating progenitor cells needed 
for tissue repair (Hadjiargyrou and O’Keefe, 2014) (Figure  1). 
As early as 1965, a paper published on Science by Urist (1965) 
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indicated that the process leading to new bone tissue formation 
was strictly related to the interactions with endogenous host cells 
and that differentiation of osteoprogenitors was elicited by local 
environment signals.
Just like different types of bone damages lead to different 
inflammatory cascades and, consequently, to different ossi-
fication processes (Colnot et  al., 2012), also the involvement 
of progenitor cells is affected. When a fracture occurs in the 
absence of stabilization, a strong periosteal reaction takes place 
and the repair process brings about the formation of a large 
callus formed through an endochondral ossification process 
(Le et al., 2001; Chang and Knothe Tate, 2012). On the contrary, 
when fractures are firmly stabilized, the periosteal reaction is 
not efficient, and a minimal callus formation is driven by an 
intramembranous ossification process (van Gastel et  al., 2014). 
In line with these concepts, holding over stabilization during 
the early phases of fracture healing does not affect either the 
volume or the mechanical properties of the callus, but it induces 
the formation of more cartilage, thus altering the involvement of 
endogenous progenitors and the modality of bone repair (Miclau 
et al., 2007). In this context, literature data indicate that different 
types of fractures cause changes in the expression of inflam-
matory genes, including matrix metalloproteinase 9 (MMP9), 
and in the subsequent activation and differentiation of resident 
periosteal progenitors (Wang et  al., 2013). Periosteum-derived 
mesenchymal progenitors are vital for both endochondral and 
intramembranous cortical bone formation (Hutmacher and 
Sittinger, 2003). The contribution of periosteal progenitors to 
callus formation was examined using a mouse model of Rosa26 
segmental bone graft transplantation (Zhang et al., 2008; Colnot 
et al., 2012). The study demonstrates that periosteal progenitors 
contribute to the initial phases of new bone formation, suggest-
ing that this resident cell population act as an essential trigger 
for bone repair processes. Indeed, periosteal progenitors can 
act directly, differentiating to cartilage/bone tissue or indirectly, 
releasing osteoinductive factors that recruit and activate other 
host-osteoprogenitors (Zhang et al., 2005), although the relative 
contribution of these two mechanisms is still not clear. In 2009, 
it has been clearly demonstrated that periosteum and endosteum, 
the main sources of resident progenitors, differently participated 
to bone repair processes. To back this up, periosteal progenitors 
show a dose-dependent migratory effect under chemokine recep-
tor ligands stimulation, such as CXCR4 and CXCR5 (Ferretti 
and Mattioli-Belmonte, 2014). Recently, using a combination 
of markers including AlphaV integrin, Chan et  al. (2015) have 
defined a skeletal stem cell population present in the proximity 
of the growth plate of long bones and capable of differentiating 
bone, cartilage, and stroma in  vivo. Meanwhile, another study 
highlighted the existence of Gremlin-1 osteochondroreticular 
(Grem1-OCR) stem cells concentrated within the metaphysis of 
long bones contributing to bone healing and possessing the ability 
to self-renew after serial transplantations (Worthley et al., 2015).
The severity of fracture healing is directly proportional to 
a reduced soft tissue envelope and “increasing severity of the 
surrounding muscle is associated with the development of non-
unions” (Friedrich et al., 2011; Papakostidis et al., 2011; Shah et al., 
2013). In light of these observations, muscle has been considered 
a “potential source of cells and signals for bone  healing” (Shah 
et al., 2013). A recent study conducted in mice using an elegant 
cell lineage tracing approach has demonstrated that muscle 
precursor cells participate in callus formation only in the case 
of open fractures with periosteal stripping and muscle injury 
(Liu et al., 2011a). Related evidence further indicate that muscle-
derived cells present within the fracture callus shift their gene 
expression from the muscle marker Paired Box Gene 3 (Pax3) 
to the chondrogenic markers SRY-Box 9 (Sox9) and Homeobox 
protein Nkx3 (Nkx3) (Cairns et al., 2012).
In addition to locally resident osteoprogenitors, other skeletal 
progenitors have been proposed to participate in bone repair pro-
cesses (Pignolo and Kassem, 2011), including circulating bone 
marrow-derived progenitors (Table 1). However, to date, a precise 
comprehension on the signals released from the injured tissues 
responsible for the mobilization of bone marrow-derived progeni-
tor cells and the accurate molecular mechanisms governing their 
fate, homing, and engraftment are very limited. Moreover, “it’s 
likely that individual circulating progenitors detected by different 
experimental strategies are overlapping but indicated with differ-
ent names, such as circulating osteoprogenitors (COPs), alkaline 
phosphatase-positive (ALP+) circulating progenitors, circulating 
CD34-positive (CD34+) precursors, contributing to increase the 
confusion regarding their exact identification” (Lo Sicco et al., 2015).
So far, a population of adherent fibroblast-like cells with osteo-
genic potential has been isolated from the blood of different spe-
cies, indicating that “cells with multiple differentiation potential 
analogous to that of post-natal marrow stromal cells can negotiate 
the circulation” (Kuznetsov et al., 2001). A first proof-of-principle 
set of experiments elucidating the differentiation potential of cir-
culating CD34-positive (CD34+) cells into not only endothelial 
cells but also osteoblasts goes back to 2008 (Matsumoto et  al., 
2008). These cells were described to create a milieu favorable 
to a functional recovery from fracture. In the same year, taking 
advantage of parabiosis experiments, it was demonstrated that 
the injury-associated signals triggered by bone fracture induced 
a stimulus for recruitment of circulating alkaline phosphatase-
positive (ALP+) cells, although the exact origin of recruited cells 
remains uncertain (Kumagai et al., 2008). More recently, a similar 
parabiotic approach was adopted to reveal that the exposure to a 
youthful circulation affected bone repair through the modulation 
of β-catenin (Baht et al., 2015), raising the possibility that agents 
that modulate this pathway could improve the extent and quality 
of fracture repair in the aging population. In 2015, the existence 
of a rare and undifferentiated cell population—circulating heal-
ing (CH) cells—involved in bone tissue healing and present in the 
peripheral blood of immunocompetent mice has been described 
(Lo Sicco et al., 2015). It has been shown how the injury signals 
were sufficient to specifically direct CH cell recruitment toward 
the fractured bone and how the peculiar local environment 
guided CH cell differentiation and appropriate integration into 
the specific tissue.
These different preclinical animal models have shown that 
small numbers of progenitor cells derived from the systemic circu-
lation participate in the bone healing process (Hadjiargyrou and 
O’Keefe, 2014). Less amount of work has been performed to study 
the involvement of progenitor cells in humans, and the results 
TABLe 1 | Resident and circulating progenitors involved in adult bone repair.








Periosteum Hedgehog (Hh) signaling 
pathway
Wang et al. (2013)






Growth plate Hh. BMP. FGF, and Notch 
signaling pathways
Chang et al., (2013),  
Chan et al. (2015)




Growth plate and 
trabecular bone
BMP signaling pathway Worthley et al. (2015)
Circulating 
progenitors
Connective tissue progenitors ALP+ Peripheral blood Injury-associated signals Kumagai et al. (2008)
Circulating osteogenic precursors CXCR4+
CD44+
CD45−
Peripheral blood BMP-2 signaling pathway Otsuru et al. (2007)
Myeloid CD34+ CD34+
OC+
Peripheral blood SDF-1 signaling pathway Matsumoto et al. (2008)
Human osteoblast lineages cells OC+
BAP+
Peripheral blood BMP signaling pathway Eghbali-Fatourechi et al. (2005)
Circulating healing cells Lineage−
CD45−
Peripheral blood Injury-associated signals Lo Sicco et al. (2015)
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obtained were controversial. Although some papers indicate that 
no circulating mesenchymal osteoprogenitors were detectable 
neither in healthy subjects nor in patients with end-stage renal 
or liver disease or in heart transplant patients (Hoogduijn et al., 
2014), COPs were identified in the blood of a single patient with 
multiple fractures (Hoogduijn et al., 2014). The authors suggested 
that disruption of bone marrow, as a result of skeletal injury, 
could have allowed egress of mesenchymal progenitors into the 
circulation (Hadjiargyrou and O’Keefe, 2014). However, several 
cell types, other than classical mesenchymal progenitors, have 
been described to undergo osteogenic differentiation and migrate 
toward an injured bone under the action of appropriate stimuli 
(Szulc, 2016). A population of circulating cells with a myeloid 
origin expressing osteocalcin and bone alkaline phosphatase 
(OC+BAP+) has been demonstrated to possess an osteogenic 
activity in  vitro and in  vivo. Interestingly, the percentage of 
myeloid OC+BAP+ cells was higher in peripheral blood and 
bone marrow of type 2 diabetic patients, and in diabetic carotid 
endarterectomy specimens, a higher degree of calcification and 
amounts of OC and BAP-expressing cells were detected in the 
α-smooth muscle actin-negative areas surrounding calcified nod-
ules, where CD68+ macrophages colocalized (Fadini et al., 2011). 
The increased percentage of COPs in pathological conditions was 
evidenced also in other clinical studies and it is supposed to be 
“linked to the presence of vascular damage, such as arterial stiff-
ness and aortic calcification” (Pal et al., 2010; Pirro et al., 2011; 
Rattazzi et al., 2016). However, in 2005, Eghbali-Fatourechi et al. 
(2005) showed that the presence of a population of osteoblast-
lineage cells circulating in physiological condition endowed with 
expression of markers of bone formation and markedly increasing 
during pubertal growth, thus representing a previously unknown 
component of bone formation process (Table 1).
COnCLUSiOn
In recent years, significant advances have been accomplished in 
the comprehension of endogenous mechanisms promoting bone 
repair. Despite these advances, a huge confusion in endogenous 
COP identification still exists. This misperception could be due 
to various causes, such as the low understanding of the molecular 
mechanisms leading to the mobilization of progenitor cells from 
the niche in which they physiologically reside, the rate of their dif-
ferentiation, and last but not least their prospective heterogeneity. 
In any case, altogether, the studies herein reviewed show the great 
potential of the endogenous repair mechanisms, envisaging new 
ways of thinking and new ways of moving forward in regenerative 
medicine.
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